Log in to search using one of your social media accounts:

 

7 medtech stories we missed this week: Nov. 17, 2017
[Image from unsplash.com]From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. The agreement comes after a strategic collaboration between the companies that allows Skyline to reach more markets. The joint venture leverages the Helomics D-Chip platform to develop and market new approaches for personalized cancer diagnostics and care. 2.&...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) mHealth (Mobile Health) Neurological Neuromodulation/Neurostimulation Regenerative Medicine Regulatory/Compliance Research & Development Helomics InnerScope iReliev LensAR Inc. Source Type: news

Varian secures Japanese clearance for Halcyon
Varian Medical Systems has received clearance from the Japanese Ministry of...Read more on AuntMinnie.comRelated Reading: Varian names new chief people officer Varian's fiscal 2017 results hold steady Varian takes orders for proton therapy system French court denies Varian effort to block Accuray deal Varian announces 1st patient treated with Halcyon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2017 Category: Radiology Source Type: news

IBA posts revenue decreases in Q3
Proton therapy firm Ion Beam Applications (IBA) posted revenue decreases for...Read more on AuntMinnie.comRelated Reading: IBA, Elekta join forces on software development IBA posts half-year revenue increases Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal IBA to show updated synthesizer at SNMMI 2017 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2017 Category: Radiology Source Type: news

Hamlin proton therapy center gets OK, construction plans to be submitted
A planned cancer-fighting medical center in the $1 billion Hamlin community got the go ahead from Orange County on Nov. 1. Construction plans will be submitted in the next few weeks for the 37,542-square-foot Provision Proton Therapy Center, project engineer Scott Gentry, principal of Orlando-based Kelly, Collins& Gentry Inc., told Orlando Business Journal. It's being developed by Provision Proton Center at Hamlin LLC, an entity related to Orlando-based Boyd Development Corp. and Knoxville, Tenn.-based … (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 1, 2017 Category: American Health Authors: Sarah Aslam Source Type: news

Varian Names New Chief People Officer, SVP HR
Terilyn Juarez Monroe named to replace retiring Wendy Scott PALO ALTO, Calif., Oct. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has named Terilyn Juarez Monroe as Chief People Officer, sen... Devices, Oncology, Personnel Varian Medical Systems, proton therapy, radiotherapy, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 30, 2017 Category: Pharmaceuticals Source Type: news

Proton therapy for prostate cancer is advantageous to imrt according to new study
(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2017 Category: International Medicine & Public Health Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients
(University of Pennsylvania School of Medicine) Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news

Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news

IBA, Elekta join forces on software development
Proton therapy firm Ion Beam Applications (IBA) and radiation oncology vendor...Read more on AuntMinnie.comRelated Reading: IBA posts half-year revenue increases Elekta adds members to MR-Linac Consortium Elekta promotes 21 studies at AAPM 2017 Elekta to install Bhutan's 1st linear accelerator Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news

Elekta inks stereotactic development, software, co-marketing deals
Medical software and equipment company Elekta has signed separate deals with Ion Beam Applications and Brainlab to share and integrate their technologies. In the memorandum of understanding with Ion Beam Applications, the two companies agreed to collaborate on investment in software development and the sale and marketing of each other’s products through a joint portfolio. Elekta specializes in technological solutions for improving, prolonging and saving the lives of patients with cancer and brain disorders, while IBA develops solutions for the diagnosis and treatment of cancer. Specifically, the companies plan to foc...
Source: Mass Device - September 25, 2017 Category: Medical Devices Authors: Alex Beall Tags: Business/Financial News Wall Street Beat Elekta Source Type: news

Mevion files for FDA clearance for S250i proton therapy system
Mevion Medical Systems said yesterday it submitted a 510(k) premarket notification to the FDA for its Mevion S250i proton therapy system with Hyperscan pencil beam scanning tech. The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said. “We focused on addressing the challenges clinicians faced with 1st generation systems and engineered a novel and transformative solution,” CEO Joseph Jachinowski said in a press release. The system also features the company’s Adaptive Apert...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Oncology Regulatory/Compliance Mevion Medical Systems Source Type: news

Mevion submits 510(k) to FDA for proton therapy system
Mevion Medical Systems has submitted a 510(k) premarket notification to the...Read more on AuntMinnie.comRelated Reading: Mevion touts scanning milestone Mevion joins forces with MedPhoton Mevion completes milestone installation Mevion completes Fla. installation Mevion, RaySearch partner on info system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 18, 2017 Category: Radiology Source Type: news

MedLever and HKSH collaborate for new MR-guided proton therapy solution
MedLever and the Hong Kong Sanatorium& Hospital (HKSH) have collaborated to develop the information backbone to support the new MR-guided proton therapy solution, which is being developed at the hospital. (Source: Hospital Management)
Source: Hospital Management - September 12, 2017 Category: Hospital Management Source Type: news

Brain imaging can't prove chronic pain
A task force of the International Association for the Study of Pain has concluded...Read more on AuntMinnie.comRelated Reading: fMRI, EEG may detect consciousness in TBI patients EEG device could reduce head CT scans Calif. center to explore proton therapy for pain relief Diagnosing chronic back pain: More than just looking at images MR spots reason for chronic groin pain, but may not alter management (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news

IBA posts half-year revenue increases
Proton therapy firm Ion Beam Applications (IBA) posted revenue increases for...Read more on AuntMinnie.comRelated Reading: Philips, Varian, IBA partner on Singapore cancer center IBA inks Va. installation deal IBA to show updated synthesizer at SNMMI 2017 IBA posts healthy Q1 revenue rise IBA Molecular forms Curium as new radiopharmacy player (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2017 Category: Radiology Source Type: news

Belgium ’ s Ion Beam Applications dives on slowing growth
(Reuters) — Belgian proton therapy specialist Ion Beam Applications (EBR:IBAB) lost a third of its $1 billion market value today after it cut its guidance for 2018 and 2019, blaming project delays and increased competition. The company is a leading maker of machines that deliver cancer-fighting proton beams, a super-precise form of radiation, but it has been beset by delays in the construction of buildings to house its proton therapy systems by third-party contractors. IBAB shares closed down -35.1% at €20.00 ($23.64) apiece today in Brussels. “The first half of 2017 has been slower, in line with the ...
Source: Mass Device - August 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Radiosurgery Wall Street Beat ionbeamapplications Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 21, 2017 Category: Health Management Authors: Veronica Brezina Source Type: news

$1B Hamlin community 1 step closer to getting proton therapy center
The new facility will create about 100 new clinical and administrative jobs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 21, 2017 Category: Biotechnology Authors: Veronica Brezina Source Type: news

Proton Therapy Insurance Coverage: Fair or Foul? Proton Therapy Insurance Coverage: Fair or Foul?
At one center, the vast majority of requests for coverage for treatment of a set of cancers were approved, although some approvals required going through an appeal process. But was this well done?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Insurers reverse 97% of pediatric proton denials on appeal
Insurance companies wind up covering proton therapy treatment for pediatric...Read more on AuntMinnie.comRelated Reading: How to avoid radiology claim denials: Medical necessity Pediatric proton therapy treatments on the rise (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2017 Category: Radiology Source Type: news

97 percent of insurance denials in pediatric proton patients overturned on appeal
(University of Pennsylvania School of Medicine) Insurance companies end up covering proton therapy treatment for pediatric cancer patients in 97 percent of the cases they originally deny once those decisions are appealed. Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed five years of coverage decisions at Penn's Roberts Proton Therapy Center. They discovered that roughly one in 10 pediatric cancer patients are initially denied coverage for the cutting edge and costly treatment - yet nearly all patients ultimately get approval. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 7, 2017 Category: Cancer & Oncology Source Type: news

Concurrent Chemo, Proton Therapy Promising in Advanced Lung Cancer
Five-year results of a single-institution study show that proton beam radiotherapy given concurrently with chemotherapy offers promising clinical outcomes with good toxicity results compared with historical data. (Source: CancerNetwork)
Source: CancerNetwork - August 3, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer News Source Type: news

Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer
(University of Texas M. D. Anderson Cancer Center) For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2017 Category: International Medicine & Public Health Source Type: news

90-ton cyclotron installed at new Emory Proton Therapy Center (SLIDESHOW)
A 90-ton cyclotron was installed Thursday at the new Emory Proton Therapy Center in Midtown in an event attended by Mayor Kasim Reed and Dr. Jonathan Lewin, CEO of Emory Healthcare. Check out the adjacent slideshow for photos from the event. The 90-ton piece of machinery uses powerful magnetic and electrical fields to accelerate protons to focus precisely on cancer cells. The cyclotron was driven up from the Port of Savannah by police escort. Atlanta Business Chronicle reported June 30 that the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 13, 2017 Category: Health Management Authors: Ellie Hensley Source Type: news

90-ton cyclotron installed at new Emory Proton Therapy Center (SLIDESHOW)
A 90-ton cyclotron was installed Thursday at the new Emory Proton Therapy Center in Midtown in an event attended by Mayor Kasim Reed and Dr. Jonathan Lewin, CEO of Emory Healthcare. Check out the adjacent slideshow for photos from the event. The 90-ton piece of machinery uses powerful magnetic and electrical fields to accelerate protons to focus precisely on cancer cells. The cyclotron was driven up from the Port of Savannah by police escort. Atlanta Business Chronicle reported June 30 that the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 13, 2017 Category: Biotechnology Authors: Ellie Hensley Source Type: news

American Society for Radiation Oncology Updates Insurance Coverage Recommendations for Proton Therapy
Proton beam therapy model policy recommends expanded access to advanced radiation therapy treatment for cancer patients ARLINGTON, Va., July 13, 2017 -- (Healthcare Sales & Marketing Network) -- The American Society for Radiation Oncology (ASTRO) has i... Devices, Oncology ASTRO , proton beam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2017 Category: Pharmaceuticals Source Type: news

ASTRO updates insurance coverage recommendations for proton therapy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 13, 2017 Category: Cancer & Oncology Source Type: news

Inova Health System inks $60 million proton therapy deal
Inova Health System plans to begin offering proton beam therapy at its Inova Schar Cancer Institute by 2020 after signing a $60 million contract for a proton system from Reston-based Ion Beam Applications S.A. The deal comes after Inova received regulatory permission to build a $92.3 million center that offers proton beam therapy and MRI simulator services. The project is part of broader ambitions for Inova's personalized health campus to "develop a national comprehensive cancer program for both… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 7, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

Varian Medical wins FDA nod for Halcyon radiotherapy cancer treatment system
Varian Medical (NYSE:VAR) said today it won FDA 510(k) clearance for its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline operator’s workflow, only requiring 9 steps from start to treatment, down from 30 steps in legacy machines. “We are proud that Halcyon has now received both 510(k) clearance and CE mark. With its human-centered and user-friendly design, Halcyon is engineered to revolutionize clinical workflow. These two ...
Source: Mass Device - July 3, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

City approves bond funding for high-tech cancer center
After over a year of uncertainty, the Emory Proton Therapy Center finally is slated for completion. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 30, 2017 Category: American Health Authors: Ellie Hensley Source Type: news

FDA clears Varian's Halcyon rad therapy system
The U.S. Food and Drug Administration (FDA) has cleared radiation oncology...Read more on AuntMinnie.comRelated Reading: Varian to build radiation oncology centers in Vietnam Varian awarded Thai proton therapy contract Varian installs proton therapy system in Fla. Varian launches Halcyon radiation therapy unit at ESTRO Varian adds to revenues in Q2 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 29, 2017 Category: Radiology Source Type: news

IBA to show updated synthesizer at SNMMI 2017
Proton therapy developer Ion Beam Applications (IBA) plans to show an upgraded...Read more on AuntMinnie.comRelated Reading: IBA posts healthy Q1 revenue rise IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 8, 2017 Category: Radiology Source Type: news

Varian to build radiation oncology centers in Vietnam
Radiation oncology firm Varian Medical Systems has signed an agreement with...Read more on AuntMinnie.comRelated Reading: Varian awarded Thai proton therapy contract Varian installs proton therapy system in Fla. Varian launches Halcyon radiation therapy unit at ESTRO Varian adds to revenues in Q2 Varian launches direct sales in South Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 5, 2017 Category: Radiology Source Type: news

Varian Selected to Provide First Proton Therapy System in Thailand
PALO ALTO, Calif., May 24, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR), today announced it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam® Compact single-r... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2017 Category: Pharmaceuticals Source Type: news

World-first proton CT images create a new vision for cancer treatment
(University of Lincoln) An international team of scientists has produced the world's first computerized tomography (CT) images of biological tissue using protons -- a momentous step towards improving the quality and feasibility of Proton Therapy for cancer sufferers around the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2017 Category: International Medicine & Public Health Source Type: news

Japan approves Varian Medical ’ s ProBeam proton therapy
Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its ProBeam system designed for proton therapy. Proton therapy is designed for precise treatment of certain types of cancer while providing potentially fewer side effects than conventional radiation therapy, the Palo Alto, Calif.-based company said. Varian claims that its ProBeam system is the 1st to offer fully-integrated intensity modulated proton therapy. “We are very pleased that the ProBeam system has now received Shonin approval. This approval is an important step in the growing avai...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Regulatory/Compliance Varian Medical Systems Source Type: news

Toshiba, Japanese QST tout heavy-ion therapy breakthrough
Toshiba (TYO:6502) said today that it, along with Japan’s National Institutes for Quantum and Radiological Science and Technology have developed a novel pencil beaming scanning system which they claim significantly reduces the size of the system without lowered performance. The company said that the newly designed system can be mounted on a rotating gantry with superconducing beam bending magnets, which will lead to further downsizing and weight reductions. Toshiba said it will release more details of the device this week at the 56th Annual COnference of the Particle Therapy Co-operation group in Yokohama. ...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Research & Development Toshiba Source Type: news

IBA posts healthy Q1 revenue rise
Double-digit revenue increases in all its business segments propelled proton...Read more on AuntMinnie.comRelated Reading: IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA, Nelco ink North American deal Japan OKs IBA's proton therapy system IBA reaches treatment milestone, wins UAE order (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2017 Category: Radiology Source Type: news

Varian ProBeam Proton Therapy System Receives Shonin Approval
Advanced proton therapy systems from Varian now available to cancer centers in Japan PALO ALTO, Calif., May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has received Shonin approval from th... Devices, Oncology, Regulatory Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news

7 medtech stories we missed this week: May 5, 2017
[Image from unsplash.com]From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Biomerics opening new corporate HQ Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The new facility will be 230,000 sq. ft and will be located in the International Center. It will have corporate offices, engineering offices, research and development labs and cleanroom manufacturing. Biomerics is expected to invest $38.5 million in the expansi...
Source: Mass Device - May 5, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Regulatory/Compliance Research & Development Accuray Inc. Biomerics Glytec medPhoton MedTech Mevion Medical Systems Neural Analytics RAPS Refocu Source Type: news

PET/CT helps assess pediatric brain tumor therapy
In a new study published in the May issue of the Journal of Nuclear Medicine,...Read more on AuntMinnie.comRelated Reading: SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors SNMMI: PET, MRI may predict pediatric brain tumor outcomes SNMMI: FET-PET aids pediatric brain cancer patients SNM: PET/MRI helps tumor staging for pediatric patients Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2017 Category: Radiology Source Type: news

IMRT vs Proton Therapy in Esophageal Cancer
This video reviews the advantages and disadvantages of IMRT and proton therapy for the treatment of esophageal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2017 Category: Cancer & Oncology Authors: Steven H. Lin, MD, PhD Tags: Videos Gastrointestinal Cancers Source Type: news

Mevion joins forces with MedPhoton
Proton therapy developer Mevion Medical Systems has inked a strategic agreement...Read more on AuntMinnie.comRelated Reading: Mevion completes milestone installation Mevion completes Fla. installation Mevion, RaySearch partner on info system Mevion to sharpen pencil-beam scanning at ASTRO ProNova joins forces with MedPhoton (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2017 Category: Radiology Source Type: news

Proton therapy dev ProTom Int ’ l raises $30m
Proton therapy tech developer ProTom International said today it raised $30 million in a new round of funding. The funding round will provide $30 million to the company by the end of June 2017, with $10 million already funded as of March, the company said in a press release. ProTom produces the Radiance 330 proton therapy system, designed to offer focused proton therapy treatments to cancer patients. The company said that Massachusetts General Hospital is slated to install a Radiance 330 system, which it expects will be operational in late 2017. “ProTom’s Radiance 33 is a disruptive technology that signifi...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology ProTom International Source Type: news

IBA Molecular forms Curium as new radiopharmacy player
Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt...Read more on AuntMinnie.comRelated Reading: IBA posts healthy revenue for fiscal 2016 IBA, partners to bring proton therapy to Ala. IBA Molecular finalizes purchase of Mallinckrodt unit IBA, Nelco ink North American deal IBA cyclotron opens ahead of schedule (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2017 Category: Radiology Source Type: news

Varian Medical Systems Names New CFO
PALO ALTO, Calif., April 5, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced it has named Gary E. Bischoping, Jr. of Dell Technologies as Chief Financial Officer effective May 8, 2017. Bischoping, 49, will re... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2017 Category: Pharmaceuticals Source Type: news

From the room next door to the next planet over
The new Albert Chadwick Research Room inside the Roberts Proton Therapy Center is no ordinary laboratory space. In fact, there ’s nothing else quite like it anywhere else in the United States, and whether it’s treating patients with cancer or helping NASA with its plans to send astronauts to Mars, the discoveries that could propel scientists forward will happen right here. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Cancer therapy: Tracking real-time proton induced radiation chemistry in water
Proton therapy is a promising form of radiation treatment used to kill cancerous cells and effectively halt their rapid reproduction, and the fundamental understanding for it is contained in the radiation induced water chemistry that occurs immediately after the interaction. The ensuing processes are therefore a subject of considerable scientific interest. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news